-
ECL Western Blotting Substrate: Practical Guide
2026-08-24
ECL Western Blotting Substrate (SKU K2187) is a luminol-based horseradish peroxidase detection reagent for sensitive, nonradioactive protein detection by chemiluminescence in immunoblots. It is intended for HRP-based Western blot assays using X-ray film or CCD imaging, not for fluorescent or radioisotopic detection workflows.
-
PLGA Nano-Adjuvant Enhances Mucosal Immunity in Chicks
2026-08-23
A 2026 Poultry Science study developed PEI-LSP-RA-PLGA, a layered PLGA nanoparticle adjuvant designed to combine sustained antigen delivery with intestinal immune targeting. In chicks receiving an inactivated H9N2 vaccine, the formulation enhanced systemic IgG, intestinal IgA, immune-cell responses, and intestinal tissue features while implicating CCR9/CCR6-associated chemokine signaling and mucosal immune pathways.
-
Everolimus (RAD001) Assay Workflow Guide
2026-08-22
Build more informative mTOR inhibition experiments with Everolimus (RAD001), from controlled stock preparation to orthogonal measurements of growth arrest and cell death. This workflow helps distinguish cancer cell proliferation inhibition from cytotoxicity in cell-based assays and supports better interpretation of renal and ovarian cancer models.
-
From Fluorescent Signal to Mucosal Insight
2026-08-21
How Sulfo-Cy5 carboxylic acid can help translational researchers connect nanoadjuvant biodistribution with mucosal immune function—while keeping fluorescence evidence distinct from biological causality.
-
AI-10-49 in CBFβ-SMMHC Leukemia Research
2026-08-20
AI-10-49 enables mechanism-led acute myeloid leukemia research by disrupting the CBFβ-SMMHC–RUNX1 interaction rather than applying a nonspecific cytotoxic challenge. Pairing short exposure mechanistic assays with longer-term viability, transcriptional, and in vivo studies helps connect RUNX1 reactivation to the MYCN/eIF4G1 survival axis.
-
VE-822: A Precision Assay Strategy for ATR Biology
2026-08-20
VE-822 is a potent ATR inhibitor for dissecting replication-stress signaling and therapeutic selectivity. This article develops a model-selection and assay-design framework inspired by personalized iPSC screening, offering a distinct route to stronger PDAC and DNA damage response studies.
-
Structure-Guided SARS-CoV-2 Proteomimetics
2026-08-19
This study uses structure-guided alanine mutagenesis and conformational constraint to create proteomimetics that reproduce key hACE2 recognition elements at the SARS-CoV-2 Spike receptor-binding interface. The linked construct, compound 28, disrupted S-RBD/hACE2 binding, inhibited pseudovirus entry, and showed stability and permeability characteristics relevant to intranasal antiviral development.
-
Hesperadin: Aurora B Kinase Inhibitor Workflows
2026-08-19
Hesperadin provides a practical way to connect Aurora B activity with histone H3 phosphorylation, chromosome segregation, cytokinesis, and polyploidization. This workflow-focused guide covers dose design, checkpoint-oriented assays, controls, and troubleshooting for reproducible mitosis and cancer research.
-
Triptolide (PG490): Rewiring Transcription for Translation
2026-08-18
Triptolide, also known as PG490, is more than a potent cytotoxic compound: it is a strategic perturbation tool for testing how transcriptional dependence shapes cancer, immune, inflammatory, and developmental phenotypes. This article connects its CDK7–RNA polymerase II mechanism with evidence from Xenopus pluripotency research and provides practical guidance for translational study design.
-
DAF-2 Diacetate for NO Imaging Workflows
2026-08-18
DAF-2 diacetate enables sensitive, retention-based nitric oxide measurements across live cells, tissue preparations, and exploratory plant assays. This guide translates its chemistry into practical workflows for NO signaling studies, including sulfur-dependent soybean nodule senescence, with controls and troubleshooting strategies for reliable interpretation.
-
Obeticholic Acid: FXR Strategy for Fibrosis Research
2026-08-17
A translational framework for using Obeticholic Acid as an FXR-centered tool in bile acid regulation, cholestasis, portal hypertension, hepatic inflammation, and liver fibrosis research, while distinguishing established target biology from emerging combination hypotheses.
-
Meropenem trihydrate in Resistance Research
2026-08-17
Build reproducible susceptibility, resistance-phenotyping, and metabolomics workflows around a broad-spectrum carbapenem antibiotic. Meropenem trihydrate helps connect routine bacterial assays with LC-MS/MS studies of carbapenemase-producing Enterobacterales and carefully controlled infection models.
-
Moxifloxacin: A Mechanism-First Assay Guide
2026-08-16
Moxifloxacin is a fluoroquinolone antibiotic with applications extending from bacterial DNA topology assays to antibiotic toxicity research. This mechanism-first guide connects molecular target engagement with retinal-cell, metabolic, and in vivo readouts while defining practical interpretation limits.
-
RIPostC, Ketone Bodies, and Ferroptosis in Stroke
2026-08-15
The 2024 ACS Chemical Neuroscience study identifies ketone body production as a mechanistic link between remote ischemic postconditioning and reduced ferroptotic injury after ischemic stroke. Its combination of rat middle cerebral artery occlusion, HT22 oxygen-glucose deprivation/reoxygenation, metabolic profiling, and ferroptosis assays provides a framework for testing ketone-centered neuroprotection.
-
Adipose-Neural Signaling in Cardiac Arrhythmia
2026-08-14
Fan et al. developed a stem cell-based coculture model showing how epicardial adipose tissue can influence cardiac electrical instability through a leptin–sympathetic neuron–NPY/Y1R pathway. The study connects adipose-derived signaling with NCX and CaMKII activity and supports the adipose-neural axis as a mechanistic framework for arrhythmia research.